Clinical Pharmacology Intern (Boston, MA, US)
About Servier
Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision. Role Summary
Servier is searching for a dynamic Clinical Pharmacology Intern to join our growing Clinical Pharmacology team in US. The intern will be responsible (1) to advance our AI/ML-driven approach to predicting drug-drug interactions (DDIs) in early drug development, and (2) to analyse and understand FDA and EMA review trends concerning special populations with organ impairment (hepatic and renal impairment) in drug development, leveraging Large Language Models (LLMs) and Artificial Intelligence (AI).
You will contribute to an innovative research initiative that evaluates the integration of machine learning with physiologically based pharmacokinetic (PBPK) modelling and special populations with organ impairment to improve clinical dose projections for oncology therapeutics. You'll collaborate with cross-functional teams spanning drug metabolism, clinical pharmacometrics, and computational biology to evaluate the potential of develop a hybrid AI and PBPK/Special Populations framework.
This role includes the unique exposure to regulatory science, clinical translation, and AI applications in pharmaceutical development, and you'll have the opportunity to coauthor a publication or more.
Primary Responsibilities
AI/ML PBPK Modelling
Conduct literature review on PBPK limitations in predicting DDIs
Collect and curate clinical DDI datasets for AI/ML training
Develop and test hybrid AI/ML-PBPK models
Validate models against clinical case studies and regulatory submissions
Document methodology and prepare summary reports for publication consideration
AI/LLM Special Populations Modelling
Identify and Extract Relevant Data: Systematically identify and extract relevant documents from FDA and EMA public repositories
Develop AI/LLM Capabilities: Train or fine-tune LLMs to accurately interpret and categorize complex regulatory documents
Analyze Review Trends: Identify trends in FDA and EMA reviews related to hepatic and renal impairment, including:
Common challenges and considerations raised by regulators
Guidance documents and their impact
Specific requirements for special population studies, e.g. oncology trials vs. other indications
Differences in review approaches between FDA and EMA
Emerging themes or areas of focus
Understand FDA and EMA Positions on Modeling for Dose Recommendations in Organ-Impaired Patients: Specifically analyze recent review documents and guidance related to the use of popPK, PBPK modeling, and other in silico approaches for predicting drug behavior in organ-impaired populations
Evaluate approaches applied for Servier molecules in multiple therapeutic area with primary focus on Oncology compounds
Summarize lessons learned to guide molecules for future programs
Present in a clinical pharmacology team and cross-functional Translational Medicine team
Education and Required Skills
Current PharmD or PhD candidate in Pharmaceutical Sciences, Pharmacokinetics, Data Science, or related field
Scientific knowledge of PBPK modelling concepts and AI/LLM/ML driven approaches to data analysis
Experience with machine learning frameworks (Python, R, HuggingFace)
Familiarity with clinical pharmacology and drug development, specifically related to drug-drug interaction and special population studies
Team player with inter-personal skills
Excellent written and communication skills
Must be able to commit to the entire duration of the internship
Travel and Location
Remote with potentially 1-2 visits over the internship period to the Boston US Headquarters (200 Pier 4 Blvd, Boston, MA 02210)
Servier’s Commitment
Servier is committed to modeling diversity, equity, and inclusion within the industry. We are dedicated to fostering an environment that maintains equitable treatment for all and we welcome applicants who are passionate, committed, and innovative individuals. We encourage candidates to apply to our open roles as we are always willing to consider experiences and skills beyond what is listed in the job description.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
The pay range for this role is $34-$44/hr. An intern’s pay position within the range will be based on several factors including, but not limited to, relevant education, qualifications, certifications, experience, skills, geographic location, performance, and business or organizational needs. We may ultimately pay more or less than the posted range, and the range may be modified in the future.
Apply Now
Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision. Role Summary
Servier is searching for a dynamic Clinical Pharmacology Intern to join our growing Clinical Pharmacology team in US. The intern will be responsible (1) to advance our AI/ML-driven approach to predicting drug-drug interactions (DDIs) in early drug development, and (2) to analyse and understand FDA and EMA review trends concerning special populations with organ impairment (hepatic and renal impairment) in drug development, leveraging Large Language Models (LLMs) and Artificial Intelligence (AI).
You will contribute to an innovative research initiative that evaluates the integration of machine learning with physiologically based pharmacokinetic (PBPK) modelling and special populations with organ impairment to improve clinical dose projections for oncology therapeutics. You'll collaborate with cross-functional teams spanning drug metabolism, clinical pharmacometrics, and computational biology to evaluate the potential of develop a hybrid AI and PBPK/Special Populations framework.
This role includes the unique exposure to regulatory science, clinical translation, and AI applications in pharmaceutical development, and you'll have the opportunity to coauthor a publication or more.
Primary Responsibilities
AI/ML PBPK Modelling
Conduct literature review on PBPK limitations in predicting DDIs
Collect and curate clinical DDI datasets for AI/ML training
Develop and test hybrid AI/ML-PBPK models
Validate models against clinical case studies and regulatory submissions
Document methodology and prepare summary reports for publication consideration
AI/LLM Special Populations Modelling
Identify and Extract Relevant Data: Systematically identify and extract relevant documents from FDA and EMA public repositories
Develop AI/LLM Capabilities: Train or fine-tune LLMs to accurately interpret and categorize complex regulatory documents
Analyze Review Trends: Identify trends in FDA and EMA reviews related to hepatic and renal impairment, including:
Common challenges and considerations raised by regulators
Guidance documents and their impact
Specific requirements for special population studies, e.g. oncology trials vs. other indications
Differences in review approaches between FDA and EMA
Emerging themes or areas of focus
Understand FDA and EMA Positions on Modeling for Dose Recommendations in Organ-Impaired Patients: Specifically analyze recent review documents and guidance related to the use of popPK, PBPK modeling, and other in silico approaches for predicting drug behavior in organ-impaired populations
Evaluate approaches applied for Servier molecules in multiple therapeutic area with primary focus on Oncology compounds
Summarize lessons learned to guide molecules for future programs
Present in a clinical pharmacology team and cross-functional Translational Medicine team
Education and Required Skills
Current PharmD or PhD candidate in Pharmaceutical Sciences, Pharmacokinetics, Data Science, or related field
Scientific knowledge of PBPK modelling concepts and AI/LLM/ML driven approaches to data analysis
Experience with machine learning frameworks (Python, R, HuggingFace)
Familiarity with clinical pharmacology and drug development, specifically related to drug-drug interaction and special population studies
Team player with inter-personal skills
Excellent written and communication skills
Must be able to commit to the entire duration of the internship
Travel and Location
Remote with potentially 1-2 visits over the internship period to the Boston US Headquarters (200 Pier 4 Blvd, Boston, MA 02210)
Servier’s Commitment
Servier is committed to modeling diversity, equity, and inclusion within the industry. We are dedicated to fostering an environment that maintains equitable treatment for all and we welcome applicants who are passionate, committed, and innovative individuals. We encourage candidates to apply to our open roles as we are always willing to consider experiences and skills beyond what is listed in the job description.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
The pay range for this role is $34-$44/hr. An intern’s pay position within the range will be based on several factors including, but not limited to, relevant education, qualifications, certifications, experience, skills, geographic location, performance, and business or organizational needs. We may ultimately pay more or less than the posted range, and the range may be modified in the future.
Apply Now